Efficacy and safety of tigecycline: a systematic review and meta-analysis

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia: European Experience

(2014) N. Dartois et al.   JOURNAL OF CHEMOTHERAPY

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections - The European Experience

(2014) P. Fomin et al.   JOURNAL OF CHEMOTHERAPY

Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections - A European Perspective

(2014) J. Teras et al.   JOURNAL OF CHEMOTHERAPY

Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov

(2013) Florence T. Bourgeois   ANNALS OF INTERNAL MEDICINE

Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan

(2011) Yin-Ching Chuang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Expérience de l’utilisation de la tigécycline dans le traitement des infections sévères en réanimation : une étude pilote

(2010) B. Jung et al.   ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION

Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline

(2010) Herwig Pieringer et al.   ANNALS OF HEMATOLOGY

Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

(2010) M. Paul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease

(2010) Yun Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial

(2010) Zhangjing Chen et al.   BMC INFECTIOUS DISEASES

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections

(2010) S. Towfigh et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

(2010) Antonio T. Freire et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections

(2010) Peter J. Petersen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Superinfection during treatment of nosocomial infections with tigecycline

(2010) E. García-Cabrera et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials

(2009) David Gardiner et al.   CLINICAL INFECTIOUS DISEASES

Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization

(2009) Matthew E Falagas et al.   Expert Review of Anti-Infective Therapy

A review of tigecycline — the first glycylcycline

(2009) Lance R. Peterson   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Tigecycline-induced acute pancreatitis: case report and literature review

(2009) Whitney Y. Hung et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint

(2009) Olaf Burkhardt et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

(2009) N. C. Gordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

(2009) Cristina Tanaseanu et al.   BMC Pulmonary Medicine

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

(2008) K. B. Anthony et al.   CLINICAL INFECTIOUS DISEASES

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

(2008) Cristina Tanaseanu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

(2008) Carlos Bergallo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

(2008) I. Florescu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

(2008) K. Vasilev et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit

(2008) S. Swoboda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

(2008) D. E. Karageorgopoulos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS

(2008) Allena J. Ji et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS